Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).

  • García-Quintáns, Nieves
  • Santiago-Sacristan, Silvia
  • Márquez-López, Cristina
  • Sánchez-Ramos, Cristina
  • Martinez-de-Benito, Fernando
  • Siniscalco, David
  • González-Guerra, Andrés
  • Camafeita, Emilio
  • Roche-Molina, Marta
  • Lytvyn, Mariya
  • Morera, David
  • Guillen, María I
  • Sanguino, María A
  • Sanz-Rosa, David
  • Martin-Perez, Daniel
  • Garcia, Ricardo
  • Bernal, Juan Antonio
The most prevalent genetic form of inherited arrhythmogenic cardiomyopathy (ACM) is caused by mutations in desmosomal plakophilin-2 (PKP2). By studying pathogenic deletion mutations in the desmosomal protein PKP2, here we identify a general mechanism by which PKP2 delocalization restricts actomyosin network organization and cardiac sarcomeric contraction in this untreatable disease. Computational modeling of PKP2 variants reveals that the carboxy-terminal (CT) domain is required for N-terminal domain stabilization, which determines PKP2 cortical localization and function. In mutant PKP2 cells the expression of the interacting protein MYH10 rescues actomyosin disorganization. Conversely, dominant-negative MYH10 mutant expression mimics the pathogenic CT-deletion PKP2 mutant causing actin network abnormalities and right ventricle systolic dysfunction. A chemical activator of non-muscle myosins, 4-hydroxyacetophenone (4-HAP), also restores normal contractility. Our findings demonstrate that activation of MYH10 corrects the deleterious effect of PKP2 mutant over systolic cardiac contraction, with potential implications for ACM therapy.